about
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that...
Read More
16.00
0.16
(1.01%)
214.8K
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Upstream Bio Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..